ASBP

Aspire Biopharma Holdings, Inc. Common Stock
ASBP

Overview Fund Activity

54 hedge funds and large institutions have $241M invested in Aspire Biopharma Holdings, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+54
Holders Change %
–
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
54
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$21M
2
GCL
2
Glazer Capital LLC
New York
$20.4M
3
SCM
3
Saba Capital Management
New York
$19.6M
4
AA
4
AQR Arbitrage
Connecticut
$13.4M
5
HCM
5
Highbridge Capital Management
New York
$11.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$4K +$4K +356 New
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$1.36K +$1.36K +135,875 New
MF
53
Magnetar Financial
Illinois
$1.32K +$1.32K +131,750 New
1 2
3